Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carboxylic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN105254611B enables waste-to-value synthesis. Reduces toxic waste and enhances supply chain reliability for pharmaceutical intermediates.
Patent CN102070611A reveals a high-yield, two-step Hantzsch route for amlodipine intermediates, offering significant cost reduction and scalable manufacturing for global API producers.
Novel acipimox calcium salt process eliminates sulfuric acid use ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturers seeking stable intermediates.
Patent CN115819186B reveals a safer Borane-THF reduction route for 3,5-dichlorobenzyl alcohol, eliminating genotoxic impurities and reducing manufacturing costs for pharmaceutical intermediates.
Patent CN116396202A details a safe, scalable synthesis of (2S,4S)-4-fluoropyrrolidine-2-carboxylic acid using DeoxoFluor, offering significant cost reduction in API manufacturing.
Patent CN116162074A reveals a novel alcohol-washing purification method for 2,5-furandicarboxylic acid, significantly reducing acid consumption and waste treatment costs for bio-based polymer manufacturers.
Novel Ru-catalyzed asymmetric hydrogenation route for Niraparib intermediate. High yield, scalable process for pharmaceutical supply chains.
Novel metal-free synthesis of 6-fluoroimidazo[1,2-a]pyridine-3-carboxylic acid offers high purity and scalable production for pharmaceutical intermediates.
Patent CN116396204A reveals a safe, scalable isatin-based route for 4,6,7-trifluoro-1H-indole-2-carboxylic acid, replacing explosive azide chemistry with high-purity outcomes.
Novel Lewis acid catalyzed synthesis offers high purity trans-isomer selectivity for pharmaceutical intermediate manufacturing supply chains and significant cost efficiency.
Patent CN116396201A details a safe, scalable DeoxoFluor route for (2R,4R)-4-fluoropyrrolidine-2-carboxylic acid, offering significant cost and safety advantages over traditional DAST methods.
Novel synthesis route for Tamiflu intermediate avoiding toxic selenium. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Advanced patent CN107954919B reveals a green Fischer indole route for Rucaparib intermediates, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel 3-step route for kinase inhibitor intermediates eliminates high-pressure CO. Enhances safety and scalability for reliable pharmaceutical supply chains.
Novel Pd/Ag catalyzed CO2 fixation route for high-purity polyimide monomers. Reduces waste and cost significantly for electronic chemical manufacturing.
Patent CN101481381B introduces a green aqueous method for Ciprofloxacin production using Lewis acid catalysts, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel patent CN105085276A enables high-yield Eltrombopag intermediate production with significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel synthesis method for L-azetidine-2-carboxylic acid offering high purity and scalable production for agrochemical applications and fungicide development.
Novel one-pot synthesis for Teneligliptin intermediate offers high purity and cost efficiency for pharmaceutical manufacturing supply chains globally.
Novel metal powder reduction method replaces cryogenic butyllithium routes for 2-methyl thiophene derivatives, offering significant cost reduction and scalability for pharmaceutical intermediates.